This session will feature two engaging talks from:
Prof Barbara McGowan: An update on pharmacotherapy for the treatment of obesity
Barbara is a Consultant Endocrinologist at Guy's and St Thomas' NHS FT and the clinical lead for obesity. She is an investigator for several clinical trials in gut hormone therapies for obesity and was awarded an NIHR/RCP/CRN prize in recognition of outstanding research within the NHS. Prof McGowan is a Board member for the International Society for Endocrinology and co-chairs EASO’s Obesity Task Force. She is the recipient of the 2024 KCL Faculty of Life Sciences and Medicine Research Impact on Society Award and the 2025 Outstanding Clinical Practitioner Award by the Society for Endocrinology.
Dr Claudia Coelho: Insights into current and future research opportunities in obesity
Claudia is a Diabetes and Endocrinology consultant at Guy’s and St Thomas’ NHS FT. She completed her specialist training in Braga, Portugal, and holds a Master’s in Clinical Nutrition as well as a postgraduate qualification in Metabolism. Claudia has contributed to research in her field with several published works. She is a national clinical fellow of the European Association for the Study of Obesity and is the lead for the UK Association for the Study of Obesity Centres for Obesity Management. She is the medical lead for the South East London Tier 3 Weight Management Programme and is a sub-investigator on multiple clinical trials focusing on obesity and diabetes. As an active clinician, Claudia has extensive experience managing patients with severe and complex obesity and her special interests include very low-calorie diets and obesity pharmacotherapy.